• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织蛋白酶E与人类胃癌发生过程中肠化生的亚型

Cathepsin E and subtypes of intestinal metaplasia in carcinogenesis of the human stomach.

作者信息

Lin C K, Lai K H, Lo G H, Cheng J S, Hsu P I, Mok K T, Tseng H H

机构信息

Department of Internal Medicine, Kaohsiung Veterans General Hospital, Taiwan, ROC.

出版信息

Zhonghua Yi Xue Za Zhi (Taipei). 2001 Jun;64(6):331-6.

PMID:11534800
Abstract

BACKGROUND

Cathepsin E is found mainly over the gastric surface and foveolar epithelial cells, and it also is found in the metaplastic pyloric glands and cancer cells. The exact function of cathepsin E in gastric mucosa remains unclear. The colonic type (type III) of intestinal metaplasia (IM) is strongly associated with intestinal-type gastric carcinoma. IM is considered to be a precancerous lesion. The aim of this study was to find out the role of cathepsin E in IM, dysplasia and cancer of stomach.

METHODS

Sixty nine biopsy specimens with IM and dysplasia and 33 gastrectomy specimens with gastric carcinoma were fixed, sectioned and stained with PAS-alcian blue stain, high iron-diamine alcian blue stain to classify IM and immunohistochemical stain to localize cathepsin E. Those patients with dysplastic gastric lesions received regular endoscopic follow-up.

RESULTS

Fifteen of 69 patients with gastric dysplasia developed cancer in a median 10.5 months follow-up. Severe dysplasia developed carcinoma significantly higher than mild dysplasia (12/20 vs. 1/25, p < 0.001), and type III intestinal metaplasia seemed to have significantly predilection for severe dysplasia and gastric cancer. Cathepsin E was stained in intestinal metaplasia with dysplastic change in 44/69 specimens (63.8%), and carcinoma in 28/48 (58.3%) specimens, there was no significant difference between intestinal type and diffuse type carcinoma in cathepsin E staining. The positive staining for cathepsin E decreased significantly in severe dysplastic gastric mucosa.

CONCLUSIONS

Type III IM is commonly associated with severe dysplasia and cancer; it may be a precancerous lesion. The positive staining of cathepsin E decreased with the severity of gastric dysplasia, representing dedifferentiation of the cells.

摘要

背景

组织蛋白酶E主要存在于胃表面和胃小凹上皮细胞,也存在于化生的幽门腺和癌细胞中。组织蛋白酶E在胃黏膜中的具体功能尚不清楚。结肠型(III型)肠化生(IM)与肠型胃癌密切相关。IM被认为是一种癌前病变。本研究的目的是探讨组织蛋白酶E在胃IM、发育异常和癌症中的作用。

方法

69例有IM和发育异常的活检标本以及33例胃癌胃切除标本进行固定、切片,并用PAS-阿尔辛蓝染色、高铁二胺阿尔辛蓝染色对IM进行分类,免疫组化染色定位组织蛋白酶E。那些有发育异常胃病变的患者接受定期内镜随访。

结果

69例胃发育异常患者中有15例在中位随访10.5个月时发生癌症。重度发育异常发展为癌的比例显著高于轻度发育异常(12/20对1/25,p<0.001),III型肠化生似乎对重度发育异常和胃癌有显著的偏好。44/69例(63.8%)有发育异常改变的肠化生标本中组织蛋白酶E呈阳性染色,28/48例(58.3%)癌标本中呈阳性染色,组织蛋白酶E染色在肠型和弥漫型癌之间无显著差异。在重度发育异常的胃黏膜中,组织蛋白酶E的阳性染色显著降低。

结论

III型IM常与重度发育异常和癌症相关;它可能是一种癌前病变。组织蛋白酶E的阳性染色随胃发育异常的严重程度而降低,代表细胞的去分化。

相似文献

1
Cathepsin E and subtypes of intestinal metaplasia in carcinogenesis of the human stomach.组织蛋白酶E与人类胃癌发生过程中肠化生的亚型
Zhonghua Yi Xue Za Zhi (Taipei). 2001 Jun;64(6):331-6.
2
Intestinal metaplasia of the gastric cardia.贲门肠化生
Am J Gastroenterol. 1997 Mar;92(3):414-8.
3
[Gastric dysplasia: its incidence in precancerous conditions, advanced cancer and early cancer].[胃发育异常:其在癌前病变、进展期癌和早期癌中的发生率]
Acta Gastroenterol Latinoam. 1988;18(4):231-48.
4
bcl-2 protein expression in gastric remnant mucosa and gastric cancer 15 or more years after partial gastrectomy.胃部分切除术后15年及更长时间胃残余黏膜和胃癌中bcl-2蛋白的表达
Mod Pathol. 1997 Oct;10(10):1021-7.
5
Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.幽门螺杆菌感染与胃黏膜肠上皮化生或异型增生中环氧合酶-2 和血管内皮生长因子表达的相关性。
J Gastroenterol Hepatol. 2010 Apr;25(4):795-9. doi: 10.1111/j.1440-1746.2009.06168.x.
6
[Expression of intestine-specific transcription factor CDX2 in different subtypes of intestinal metaplasia and gastric carcinoma].[肠特异性转录因子CDX2在不同亚型肠化生及胃癌中的表达]
Ai Zheng. 2006 Feb;25(2):185-9.
7
Distribution of marker enzymes and mucin in intestinal metaplasia in human stomach and relation to complete and incomplete types of intestinal metaplasia to minute gastric carcinomas.人胃肠化生中标记酶和黏蛋白的分布及其与微小胃癌肠化生完全型和不完全型的关系
J Natl Cancer Inst. 1980 Aug;65(2):231-40.
8
Expression of GCRG213p, LINE-1 endonuclease variant, significantly different in gastric complete and incomplete intestinal metaplasia.GCRG213p 的表达在胃完全和不完全肠化生中存在显著差异,LINE-1 内切酶的变体。
Diagn Pathol. 2019 Jun 21;14(1):61. doi: 10.1186/s13000-019-0838-9.
9
[Expression of pi glutathione S-transferase in intestinal metaplasia and its relationship with Helicobacter pylori infection].[π谷胱甘肽S转移酶在肠化生中的表达及其与幽门螺杆菌感染的关系]
Zhonghua Yi Xue Za Zhi. 2002 Aug 10;82(15):1033-6.
10
[Preneoplastic lesions associated with carcinoma of the stomach: retrospective study of 125 gastrectomy pieces].[与胃癌相关的癌前病变:125份胃切除标本的回顾性研究]
Rev Esp Enferm Apar Dig. 1989 Jun;75(6 Pt 2):676-9.

引用本文的文献

1
Identification and Quantification of Iron Metabolism Landscape on Therapy and Prognosis in Bladder Cancer.膀胱癌治疗与预后中铁代谢图谱的识别与定量分析
Front Cell Dev Biol. 2022 Feb 21;10:810272. doi: 10.3389/fcell.2022.810272. eCollection 2022.
2
Helicobacter pylori and gastric cancer: a lysosomal protease perspective.幽门螺杆菌与胃癌:从溶酶体蛋白酶角度看。
Gastric Cancer. 2022 Mar;25(2):306-324. doi: 10.1007/s10120-021-01272-8. Epub 2021 Dec 16.
3
High-risk individuals for gastric cancer would be missed for surveillance without subtyping of intestinal metaplasia.
如果不对肠上皮化生进行亚型分类,将会错过胃癌的高危人群的监测。
Virchows Arch. 2021 Oct;479(4):679-686. doi: 10.1007/s00428-021-03116-3. Epub 2021 May 14.
4
Cathepsin E expression and activity: Role in the detection and treatment of pancreatic cancer.组织蛋白酶 E 的表达和活性:在胰腺癌检测和治疗中的作用。
Pancreatology. 2019 Oct;19(7):951-956. doi: 10.1016/j.pan.2019.09.009. Epub 2019 Sep 20.
5
Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis.胃癌患者伴胃萎缩和肠化生:系统评价和荟萃分析。
PLoS One. 2019 Jul 26;14(7):e0219865. doi: 10.1371/journal.pone.0219865. eCollection 2019.
6
Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence.肠上皮化生亚型作为胃癌风险标志物的效用。证据综述。
Int J Cancer. 2013 Sep 1;133(5):1023-32. doi: 10.1002/ijc.28003. Epub 2013 Feb 5.
7
Molecular imaging of Cathepsin E-positive tumors in mice using a novel protease-activatable fluorescent probe.使用新型蛋白酶激活荧光探针在小鼠体内对组织蛋白酶E阳性肿瘤进行分子成像。
Mol Biosyst. 2011 Dec;7(12):3207-3213. doi: 10.1039/c1mb05215b. Epub 2011 Sep 20.